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Abstract T is a transcription factor which activates transcrip-
tion by binding to repeated arrangements of the dodecamer 
5'-AGGTGTGAAATT-3'. Using in vitro synthesised T protein, 
we have demonstrated that T binds to its target DNA as a 
homodimer and that truncated protein containing only the N-
terminal 233 amino-acid residues, which comprise the DNA-
binding domain, can form a dimer. We also report a common 
human polymorphism, Gly-177-Asp, within the DNA-binding 
domain at a position which is a conserved glycine residue in T 
homologues from other vertebrates. The proposition that T forms 
heterodimers with other members of the T-box transcription 
factor family and the implications for disorders of axial 
development are discussed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The T gene encodes a transcription factor [1-4] which is 
vital for normal formation of posterior mesoderm and for 
axial development in vertebrates. Complete deficiency of T 
in mouse (e.g. T Brachyury mutant , 7* r) and zebra fish (ntl 
mutant) is embryonic lethal and leads to failure of notochord 
differentiation and formation [5-8] and abnormal migration 
of mesoderm cells from the primitive streak; mice heterozy-
gous for mutan t alíeles exhibit abnormalities of posterior mes-
oderm development associated with short or absent tails. 
A modular structure has been defined for the T protein by 
deletion analysis in cell transfection studies [2] and by using 
heterologous expression systems [9]. DNA-binding activity is 
conferred by the N-terminal half (amino-acid residues 1-229) 
of the protein while the activation domain lies within the C-
terminal half. In the mouse, the activation domain of the T 
protein can be divided into four regions, consisting of two 
transcription activators and two repressors [2], while in Xe-
nopus and zebra fish only one activator region has thus far 
been identified [9]. The DNA-binding domain is highly con-
served and defines a novel family of transcription factors, the 
T-box proteins, members of which have been identified in man 
[10], mouse [11,12] and several invertebrates [13,14]. Some of 
these genes have also been implicated in developmental ab-
normalities and like T, are haploinsufficient. For example, 
mutat ions in the human TBX5 gene have been associated 
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with the autosomal dominant Holt-Oram syndrome [15,16], 
characterised by limb malformations and cardiac septation 
defects, while Drosophila deficient for the T-box protein, 
omb, show abnormal distal wing formation [17]. 
T protein activates transcription by binding to a specific 
D N A target sequence. The consensus binding site of T protein 
has been identified by target site selection in vitro; the pre-
ferred configurations contain either a palindromic arrange-
ment of the dodecamer 5 ' - A G G T G T G A A A T T - 3 ' or directly 
repeated dodecamer sites [1,2]. In this paper, we describe ex-
periments which indicate that T, like many other transcription 
factors, binds to its target D N A as a homodimer, and that 
amino-acid residues important for dimerization lie in the ami-
no-terminal part of the protein. We also describe a polymor-
phism within the human T DNA-binding domain which con-
ceivably could affect T dimer stability in vivo. 
2. Materials and methods 
2.1. Protein synthesis 
RNA was prepared from intervertebral discs, dissected to remove 
the outer rings of collagen fibres, taken from human 10-13-week 
gestation fetal samples. First-strand cDNA was generated using ran-
dom oligonucleotide primers. Templates for the synthesis of mRNA 
encoding the DNA-binding domain of human T [18] were constructed 
by polymerase chain reaction (PCR) amplification in two stages. In 
the first stage, cDNA was amplified using a Γ-specific forward primer 
corresponding to the 5' UTR sequence 5'-CAGGGAAGGTG-
GATCTCAGGTAG-3' and a reverse primer corresponding to se-
quence from the 3' end of the DNA-binding domain in exon 5, 5'-
CGGGTTCCTCCATCATCTCTTTG-3' to generate a 769-bp prod-
uct. The conditions were 15 s at 95°C, 30 s at 58°C, 45 s at 72°C for 
35 cycles. In the second stage, the product was re-amplified with a 
forward primer containing the T7 bacteriophage promoter sequence, a 
Kozak consensus, the 5' Met codon (underlined) and 21 bp of 
5' protein-coding sequence (5'-GGATCCTAATACGACTCACTA-
TAGGAACAGACCAC CATGAGCTCCCCTGGCACCGAGAGC-
3'). The conditions were 15 s at 95°C, 30 s at 65°C, 45 s at 72°C for 
35 cycles and the product size 736 bp. The PCR product was purified 
after electrophoresis by electro-elution and re-amplified. Diagnostic 
BamHI digests and PCR amplification using internal primers were 
used to confirm that the DNA-binding domain (aa 1-233) was cor-
rectly amplified. 
35S-methionine-labelled human T DNA-binding domain protein 
was synthesised by in vitro transcription and translation using a 
Promega TNT T7-coupled reticulocyte lysate system according to 
the supplier and using between 200 and 400 ng of purified PCR 
product. Full-length mouse T protein (436 aa) was also synthesised 
using as template full-length mouse cDNA cloned downstream of a 
T7 promoter in the pCR 3 vector. The size and integrity of in vitro 
translated proteins were checked by SDS-PAGE. The amount of 
T protein synthesised (cpm 35S-methionine) was quantified in two 
ways. Firstly, by trichloroacetic acid (TCA) precipitation and scintil-
lation counting according to standard procedures. Secondly, by 
phosphoimaging of the SDS gel; signals of individual bands were 
quantified using a phosphoimager (Fujix BAS1000) and MacBAS 
V2.0 software. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 5 0 6 - l 
202 C. Papapetrou et al.lFEBS Letters 409 (1997) 201-206 
2.2. Single strand conformation polymorphism (SSCP) analysis and 
genotype analysis 
Primers derived from introns 2 and 3 of the human T gene [18] 
TX3F 5'-TGCCACCAATCCTGTATCTGTCTC-3' TX3R 5'-AAG-
CGATCCGCCTCTGTCCTTCTCA-3 were used to amplify exon 3 
DNA from unrelated human individuals and gorillas. The PCR con-
ditions were 15 s at 95°C, 30 s at 65°C and 30 s at 72°C for 5 cycles 
and 15 s at 95°C, 30 s at 63°C and 30 s at 72°C for 30 cycles. PCR 
product samples were mixed 1 : 1 with loading buffer (95% forma-
mide, 20 mM EDTA, 0.05% bromophenol blue), heated to 97°C for 
10 min and snap-cooled on ice. Primers were also designed to amplify 
part of exon 3 of the mouse gene as follows: mTX3F 5'-CCTTGCA-
TAAGTATGAACCTCGG-3' mTX3R 5'-TATGAACTGGGTCT-
CGGGAAAGC-3' and the PCR conditions were 15 s at 95°C, 30 s 
at 56°C and 30 s at 72°C for 35 cycles. Electrophoresis was carried out 
in a 10% polyacrylamide gel (66.7:1) in 0.5XTBE (45 mM Tris, 
45 mM borate, 1 mM EDTA) at 300 V for 1.75 h at room temper-
ature. The gels were washed/fixed in ethanol/acetic acid and stained 
using silver nitrate and sodium borohydride as described by Harvey 
et al. [19]. 
2.3. Electrophoretic mobility shift assays 
The DNA probe used in electrophoretic mobility shift assays was 
the BS.p-binding site described by Kispert and Herrmann [1] which 
represents a 24-bp palindromic fragment flanked by Smal half sites. 
Double-stranded oligonucleotides were chemically synthesised (Oswel, 
Edinburgh, UK), annealed in 100 mM NaCl and labelled using T4 
polynucleotide kinase and [γ32Ρ]ΑΤΡ (Amersham, UK). 
Aliquots of in vitro translated T protein were pre-incubated at 25°C 
for 20 min with 1 μg poly (dl-dC).poly (dl-dC) (Pharmacia), with or 
without unlabelled competitor DNA oligonucleotide (100-fold excess). 
32P-BS.p (25 000 cpm) was added to the protein and incubated at 
25°C for a further 30 min in a final volume of 20 μΐ of 10% glycerol 
(v/v), 10 μg ml - 1 bovine serum albumin, 75 mM NaCl, 25 mM 
HEPES pH 7.4, 1 mM MgCl2, 0.25 mM EDTA, 0.1% Nonidet 
P-40 (v/v), 1 mM PMSF, 1 mM DTT, 1 μg ml - 1 leupeptin, 1 μg 
ml - 1 pepstatin. Binding reactions were electrophoresed in a pre-run 
5 or 6% polyacrylamide gel in 0.5XTBE buffer at 4°C and 10 V cm - 1 
for 2.3 (5%) or 2.8 (6%) h. Gels were vacuum-dried onto 3MM paper 
and autoradiographed. In some instances, the dried gel was phos-
phoimaged and 32P signals from individual bands quantified by phos-
phoimaging as described above. 
Fig. 1. (A) EMSA of truncated human T protein (huTtr) and full-length mouse T protein (moT) with 32P-BS.p as probe. The right panel illus-
trates the effect of using increasing amounts (lanes 1-5) of huTtr in the binding assay. Fast- (L) and slow-mobility (U) DNA/huTtr protein 
complexes are indicated. (B) Graph of L/U plotted against increasing huTtr concentration. 
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3. Results 
3.1. Analysis of the DNA-binding activity of truncated human 
T protein 
Intervertebral discs of 10-13-week human fetal samples 
were used to isolate human T mRNA. We have previously 
shown that T is expressed in the remnant notochord cells of 
the nucleus pulposus in the intervertebral disc and that this is 
a moderately accessible source of T mRNA [18]. Human T 
protein for DNA/protein-binding studies was generated by in 
vitro translation. T cDNA encoding the DNA-binding do-
main, aa 1-233, was amplified, tagged with a T7 polymerase 
promoter and used as template for in vitro transcription/ 
translation. Studies of mouse T protein [1,2] have shown 
that the N-terminal 229 amino acids are sufficient for DNA 
binding. As a positive control, the full-length mouse T protein 
(436 aa) was also synthesised in vitro. 
The in vitro translated proteins were examined for their 
ability to bind specifically to the synthetic target DNA se-
quence, BS.p [1], using electrophoretic mobility shift assays 
(EMSA). Both the full-length mouse protein (moT) and the 
truncated human protein (huTtr) bound to DNA (Fig. 1A). 
moT gave rise to a single slow-moving DNA/protein complex, 
while two complexes of differing mobility were detected using 
huTtr (L, fast-mobility band; U, slow-mobility band). The 
relative proportion of the two huTtr complexes was depend-
ent upon protein concentration and this is clearly demon-
strated by an experiment where the amount of protein added 
to the binding mix was varied > 5-fold (Fig. 1A). In Fig. IB, 
these data are presented graphically as a ratio of L to U; as 
the amount of protein increases, the relative proportion of the 
upper, slow band increases and L/U decreases. 
One explanation for this observation is that the slower-mo-
Fig. 3. (A) Thermostability assay of BS.p/huTtr complex. Post-bind-
ing incubations were carried out for 10 min at the temperatures in-
dicated, rt to 42°C; (rt), room temperature. 0, a binding reaction 
carried out entirely at 0°C. Fast- (L) and slow-mobility (U) DNA/ 
huTtr protein complexes are indicated by arrows. (B) Graph of L/U 
plotted against post-binding incubation temperature. 
Fig. 2. EMSA of truncated human T protein (huTtr) and full-length 
mouse T protein (moT) either seperately or together (huTtr/moT) 
with 32P-BS.p as probe. Unlabelled competitor (comp) DNA (BS.p 
or MCK) was included in the binding reaction as indicated, fp, 
probe without protein; lys, unprogrammed reticulocyte lysate. Ar-
row indicates the heterodimer complex. 
bility band represents huTtr protein binding to DNA as a 
dimer and that the faster band is huTtr binding as a mono-
mer. To test this idea, advantage was taken of the differences 
in size between the moT and huTtr polypeptides; DNA/pro-
tein-binding reactions were carried out using both proteins 
together and amounts of huTtr translation product which 
favour the formation of the putative dimer. Under these con-
ditions, a novel DNA/protein complex, consistent with the 
formation of a heterodimer between huTtr and moT was 
seen, with mobility intermediate to the complexes formed by 
huTtr and moT alone (Fig. 2). The complexes formed in the 
moT/huTtr-binding reaction were specific to the BS.p T-bind-
ing site as judged by competition assays in which excess un-
labelled BS.p competed for the formation of complexes, when 
added to the binding mix. Competition was not seen using an 
unrelated oligonucleotide probe designated MCK (Fig. 2). 
This experiment strongly suggests that T protein normally 
binds to its target DNA site as a dimer. We therefore suppose 
that the single DNA/protein complex seen using moT (full-
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Fig. 4. EMSA of huTtr cross-linked with a 10-fold molar excess of Bis(sulphosuccinimidyl)suberate (BS3). BS3 was added to the binding reac-
tion (+) either simultaneously with the BS.p probe (pre, lanes 3 and 5, left panel) or after completion of the binding reaction (lanes 2 and 4, 
left panel; lanes 1, 3 and 5, right panel). —, without cross-linker; fp, probe without protein. Arrow indicates the single complex formed in pres-
ence of cross-linker. 
length mouse T protein) contains T as a dimer, and that the 
detection of both monomer- and dimer-containing complexes 
using huTtr alone is due to the truncation of the human T 
polypeptide and consequent dimer instability. Thermostability 
studies in which the DNA/protein-binding reaction was incu-
bated, post-binding, at various temperatures show that the 
DNA/huTtr dimer complex is relatively unstable between 32 
and 37°C (Fig. 3A,B). It seemed reasonable to suppose that 
covalent cross-linking of the huTtr subunits would stabilise 
the dimeric structure. This was tested using an ε amine-spe-
cific, bifunctional reagent [BS3 Bis(sulfosuccinimidyl)suberate] 
to cross-link the huTtr protein after binding to BS.p DNA. 
Cross-linking led to the formation of a single complex with 
mobility very similar to that of the huTtr slow-mobility com-
plex, the dimeric form (Fig. 4, right hand panel). The slight 
Fig. 5. Upper panel: SSCP analysis showing human Γ exon 3 se-
quence polymorphism in DNA from 8 unrelated individuals. Lower 
panel: BamHl digestion patterns of human T exon 3 sequence from 
individuals of different phenotype. The size of the digested frag-
ments (104 and 87 bp) is indicated. 
shift in mobility of the cross-linked dimer compared to the 
non-cross-linked form can be attributed to the blocking of 
positively charged lysine amino groups by the cross-linker. 
It is of interest to note that addition of cross-linker prior to 
binding of huTtr to the DNA target inhibited DNA binding 
(Fig. 4, left hand panel), pointing to the involvement of huTtr 
lysine residues in the DNA/protein interaction. 
3.2. A common human polymorphism Gly-177-Asp affects 
dimer stability 
As part of an investigation of T as a candidate gene for 
congenital disorders of axial development, we have searched 
for mutations in the human gene. Analysis by SSCP of exon 3 
amplified from DNA of unrelated individuals has identified a 
commonly occurring structural variant (Fig. 5). Family stud-
ies show that this can be attributed to the occurrence of two 
alternative alíeles at the human T locus and sequence analysis 
has identified a G to A change at bp 530 in the human 
T-coding sequence [18]. This transition leads to the gain of 
a BamHl site (Fig. 5) and an amino-acid substitution Gly to 
Asp at aa 177. The frequency of the Asp-177 alíele in the 
British population is 0.51 and varies between 0.33 and 0.59 
amongst different populations (Papapetrou et al., 1997, per-
sonal communication). 
Amino-acid residue 177 lies in the DNA-binding domain 
within the highly conserved T-box. In T sequences of different 
chordate species, Gly occurs at this position (mouse [20], ze-
bra fish [3], Xenopus [21], chick [22], Amphioxus [23], ascidian 
tunicate [24]). Analysis of T genomic DNA by PCR and re-
striction enzyme digestion, from six different strains of mice 
(C57BL, DBA/2, CBA, P12 M. spretus and Lcells) and from 
two gorillas, showed Gly at this position in all samples. In 
mouse, Gly-177 is encoded by GGC (instead of GGT in hu-
mans) and forms an Apal site which was digested in all mouse 
strains tested. Both gorilla DNAs were digested with Avail, 
which digests the Gly-177 sequence but not Asp-177 in hu-
mans, whereas Mbol, which digests Asp-177 sequence but not 
Gly-177 in humans, did not digest either gorilla sample. 
In order to investigate whether this substitution of an un-
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Fig. 6. (A) Comparison of the DNA-binding properties of huTtr Asp-177 and huTtr Gly-177, each at five different protein concentrations. 
DNA/huTtr protein fast- (L) and slow-mobility (U) complexes are indicated by arrows. (B) Graph of L/U formed by each type of protein 
(Asp-177 and Gly-177) plotted against the amount of protein (35S cpm) added to the binding mix or (C) against the total amount of DNA/pro-
tein complex formed (PSL). 
charged amino acid by an acidic residue, in a crucial, con-
served region of the DNA-binding domain, affects the DNA-
binding characteristics of the T protein, we have carried out 
EMSAs using huTtr with either Gly or Asp at position 177. 
mRNA was prepared from fetal intervertebral discs from 8 
individuals and cDNA synthesised by RT-PCR. Samples from 
individuals homozygous for Gly-177 and Asp-177 were se-
lected by typing cDNA for the exon 3 polymorphism by Bam-
HI digestion and these samples were used for in vitro tran-
scription/translation. 
The newly synthesised Gly-177 and Asp-177 huTtr proteins 
were used in DNA/protein-binding studies. Both types of 
huTtr bind to BS.p and both form BS.p/huTtr monomer 
and dimer complexes, with higher amounts of dimer forma-
tion at increased protein concentrations. However, the two 
types of huTtr showed a difference in the relative amounts 
of the dimer and monomer BS.p/huTtr complexes they 
formed. Fig. 6 shows a typical experiment and summarises 
the data graphically, in two different ways. When the data 
are expressed as L/U for different amounts of protein (meas-
ured as 35S after TCA precipitation) added to the binding 
reaction, it can be seen that relatively more of the Gly-177 
huTtr is present as BS.p/dimer complex than for Asp-177 
huTtr at the same protein level (Fig. 6B). Similarly, when 
the results are presented as L/U for different amounts of total 
BS.p bound (measured as 32P by phosphoimaging of the 
EMSA bands), there is relatively more BS.p/dimer complex 
for Gly-177 huTtr than is found for Asp-177 huTtr at any 
level of BS.p complexed (Fig. 6C). So, for example, if lanes 2 
and 4 of the Gly-177 EMSA are compared with lanes 7 and 9 
of the Asp-177 EMSA, it can be seen that the Gly-177 sam-
ples show higher amounts of the slower-mobility, dimer com-
plex. These results show that Gly-177 huTtr and Asp-177 
huTtr differ in dimer/DNA complex stability. 
4. Discussion 
Most transcription factors, including the basic leucine-zip-
per proteins, helix-loop-helix proteins, zinc finger proteins, the 
steroid hormone receptor super family and the CCAAT/en-
hancer-binding protein family C/EBP, bind to DNA as homo-
dimers. Amongst these, two dimerization structures are rela-
tively well-understood; the leucine zipper characterized by 
heptad repeats of leucine, which adopt a coiled coil structure 
206 C. Papapetrou et al.lFEBS Letters 409 (1997) 201-206 
during dimerization, and the helix-loop-helix structure, two 
short amphipathic helices containing hydrophobic residues 
at every third or fourth position ([25] and references therein). 
Neither of these structures is a feature of the T protein and 
the dimerization domain has yet to be clearly identified. The 
studies presented here suggest that at least part of this domain 
lies within the N-terminal half of the protein, but the relative 
instability of the dimer formed by the truncated T protein 
indicates that sequences in the C-terminal half are also re-
quired. 
The most efficient DNA-binding site for T, consists of an 
inverted repeat of the dodecameric half site separated by a 
24-bp spacer [2]. In vitro experiments have shown that two 
half sites are required for binding and that their spacing is 
critical for transactivation [2]. These observations fit with our 
finding that T binds to DNA as a dimer, each subunit con-
tacting one half site. A further enhancement of activation is 
seen when two palindromic T sites are present and this seems 
to indicate that two protein dimers might bind to neighbour-
ing sites. 
It is now well-recognised that members of a family of tran-
scription factors bind DNA either as homodimers or as het-
erodimers with other members of the same family [25]. If the 
members of the family have distinct regulatory and functional 
properties, this offers enormous scope for diversity of gene 
regulation. The T gene is a member of a family of T-box genes 
defined by their highly conserved DNA-binding domain 
[11,14] and it is possible that T forms and functions as a 
heterodimer with other members of the T-box family. Given 
that T is only expressed in early development and is restricted 
to primitive streak, pre-notochordal mesoderm, notochord 
and tail bud, the current best candidate for a dimerization 
partner in vivo is Tbx6 [12]. Tbx6 is first detected during 
gastrulation in the primitive streak and paraxial mesoderm 
and then in the tail bud [26] and thus overlaps expression of 
T. Interaction between these two T-box proteins in the prim-
itive streak and tail bud may be essential to the normal differ-
entiation of mesoderm in these sites. The proposition that T 
acts as a dimer and in particular forms heterodimers with 
Tbx6 offers an attractive explanation for the antimorphic na-
ture of some T mutant alíeles (T, T"'15, r~m) [27,28]. For 
example, it has been difficult to explain how the J^/T®1 mouse 
can show a more severe phenotype than the 7 * 7 7 ^ null (7* r, 
Brachyury, is a full deletion of the T gene). Interaction of Tc 
and Tbx6 subunits to form inactive complexes would provide 
a mechanism to explain this phenomenon. 
The finding in the human population of a common poly-
morphism Gly-177-Asp within the T-box DNA-binding do-
main is of some interest, particularly since this residue is 
highly conserved in T homologues of all vertebrate species 
sequenced thus far, and does not show common genetic var-
iation in the mouse. This high level of conservation implies a 
significant role for Gly-177 in normal T function. Modifica-
tion of this residue to Asp-177 in the human T variant iso-
form, does not prevent T binding to its target DNA site but 
appears to reduce the stability of the T dimer formed with 
truncated protein. This genetic variation may be meaningful 
in the context of human disorders of axial development. For 
example, we have recently described an association between 
an allelic variation in intron 7 of the human T gene and 
susceptibility to spina bifida [29] and are now investigating 
the distribution of the Gly-177 and Asp-177 alíeles amongst 
our neural tube defect patient samples. It may be relevant that 
Gly-177 is specific for the T gene and does not occur in other 
members of the broader T-box family. Asp-177 occurs quite 
frequently in other T-box genes, for example in mouse Tbx2 
and Tbx3, Drosophila omb and human TBX2, but in human 
TBX5 and TBR1 and mouse Tbx4, Tbx5 and Tbrl this codon 
is Glu-177 and in mouse Tbx6 is Gln-177 [12,16]. 
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